Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : PHARMACEUTICALS
BACIL PHARMA LTD.
Bacil Pharma Ltd.
BSE: 524516
|
ASM
Download real time
32.52
-1.71
(
-5.00
%)
41.34% Fall from 52W High
21,418
BSE Volume
BSE
29 Dec, 2025 11:18 AM (IST)
Watchlist
Portfolio
Alert
My Notes
TRADE STOCK
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Bacil Pharma - BACPHAR, 524516 corporate action history
Check all corporate actions such as stock splits, bonuses, dividends, mergers & acquisitions, rights issues & board meeting announcements for Bacil Pharma
GET EVENTS ALERTS
LIVE SAMPLE
Daily Digest
Bacil Pharma Bonus history
Bacil Pharma has not announced any bonus since Jan 1, 2000.
See all forthcoming Bonus and Splits
Bacil Pharma Split history
Bacil Pharma has not split the face value of the share since Jan 1, 2000.
See all forthcoming Bonus and Splits
Bacil Pharma Dividend history
Bacil Pharma has not given any dividends since Jan 1, 2000.
See all forthcoming dividends
Board Meetings - Bacil Pharma
The latest board meeting for Bacil Pharma took place on 13 Nov 2025, for the purpose of Quarterly Results
Ex-Date
Purpose
Notes
13 Nov 2025
Quarterly Results
-
05 Sep 2025
Others
Inter-alia, to consider 1. Fix Date, Place, Timing and Notice for 38th AGM of the Company. 2. Director Report of the Company for the Financial Year 2024-2025. 3. Other business matters.
25 Aug 2025
Others
Inter-alia, to consider 1. Discussion on Appointment of M/s Sarang Shivajirao Chavan & Associate as a Statutory Auditor of the Company. 2. Appointment of New Director. 3. Other business matters.
12 Aug 2025
Quarterly Results
-
16 Jul 2025
Others
Inter-alia, to consider 1. Appointment of a new Executive Director and Chief Financial Officer of the Company. 2. Resignation of the present Chief Financial Officer. 3. Other business matters.
26 May 2025
Audited Results
-
21 Jan 2025
Quarterly Results
-
23 Oct 2024
Quarterly Results
-
15 Oct 2024
Others
-
27 Sep 2024
Increase in Authorised Capital
-
See all Board Meetings for Bacil Pharma
Bacil Pharma Rights history
Bacil Pharma has not issued
any
rights since Jan 1, 2000.
See all Rights History for Bacil Pharma